Policy | December 12, 2022
National Health Ministers’ Conclave concludes in Varanasi
They also released the Operational Guidelines for Wellness activities at AB-HWCs
They also released the Operational Guidelines for Wellness activities at AB-HWCs
More women centric initiatives being the need of the hour for holistic development
The second day of Arogya Manthan 2022 had panel discussions with eminent thought leaders from relevant public and private sector organizations
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
The Bulk Drug Parks to be developed under the scheme will provide common infrastructure facilities at one place thereby creating a robust ecosystem for the bulk drug manufacturing in the country and also reducing manufacturing cost significantly
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
India exported Bulk Drugs/Drug Intermediates worth Rs. 33,320 crore in financial year 2021-22.
India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
Subscribe To Our Newsletter & Stay Updated
